QT
RUBY

Quantbot Technologies’s Rubius Therapeutics, Inc RUBY Stock Holding History

Quantbot Technologies’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,400
Closed -$1K – 2241
2022
Q3 		$1K Sell
4,400
-11,800
-73% -$8.85K ﹤0.01% 1534
2022
Q2 		$13K Buy
16,200
+6,300
+64% +$10.6K ﹤0.01% 1508
2022
Q1 		$54K Buy
9,900
+1,800
+22% +$11.4K ﹤0.01% 1181
2021
Q4 		$78K Buy
8,100
+6,200
+326% +$86K 0.01% 933
2021
Q3 		$33K Buy
1,900
+1,200
+171% +$26.1K ﹤0.01% 1181
2021
Q2 		$17K Buy
+700
New +$17.5K ﹤0.01% 1247

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's RUBY Position: Q4 2022 in Review

Quantbot Technologies sold out of Rubius Therapeutics, Inc (RUBY) in Q4 2022, closing a stake of 4,400 shares — an estimated $1K sold.

Quantbot Technologies first reported a position in RUBY in Q2 2021 and held it in 6 quarters. The position peaked at $78K in Q4 2021. 42 funds tracked by Wall St. Rank hold RUBY as of Q4 2022.

  • Quantbot Technologies reported no remaining Rubius Therapeutics, Inc position as of Q4 2022 after selling out during the quarter.
  • Quantbot Technologies sold 4,400 Rubius Therapeutics, Inc shares in Q4 2022, an estimated $1K.
  • Quantbot Technologies first reported a position in Rubius Therapeutics, Inc in Q2 2021 and held it in 6 quarters.
  • Quantbot Technologies's Rubius Therapeutics, Inc position peaked at $78K in Q4 2021.
  • 42 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q4 2022.

Based on Quantbot Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.